News

Editas Medicine Set to Present at the ESGCT Annual Congress

Editas Medicine Set to Present at the ESGCT Annual Congress

Editas Medicine's Upcoming Presentation Highlights

Editas Medicine, Inc. (NASDAQ: EDIT), a trailblazer in gene editing, is excited to announce that it will present at the renowned European Society of Gene and Cell Therapy (ESGCT) Congress. The congress is set to occur from October 7 to October 10, making this a significant occasion for the company and the field of gene therapy.

About the ESGCT Congress

The ESGCT Congress provides a vibrant platform for discussing the latest advancements in gene therapy and cell therapy, drawing experts from around the globe to exchange knowledge and collaborate on future strategies. Editas Medicine will present groundbreaking findings related to its innovative CRISPR gene editing technology during this major conference.

Details of the Presentation

During the congress, one of the highlights will be an oral presentation titled "A transformative LDL-cholesterol–lowering in vivo CRISPR gene editing medicine that functionally upregulates LDLR in mice and non-human primates." This significant research finding will be presented by Linda Burkly, Ph.D., who serves as the Executive Vice President and Chief Scientific Officer at Editas Medicine.

Session Information

The presentation is scheduled for October 9 at 5:00 p.m. CEST (11:00 a.m. ET) as part of the session focused on gene editing applications. Dr. Burkly’s research, documented in Final Abstract Number OR069, showcases the potential of gene editing as a therapeutic tool to transform healthcare.

Availability of Abstracts

For attendees and interested parties, the abstracts from the congress will be available on the ESGCT website, offering insights into the latest research presented at the event. Furthermore, for those who cannot attend, Editas Medicine will later share the presentation material on their website in the "Posters & Presentations" section.

Participation in Investor Conferences

In addition to its participation at ESGCT, Editas Medicine is set to engage in several investor conferences throughout October. These include:

  • H.C. Wainwright Genetic Medicines Virtual Conference
    Format: Fireside Chat
    Date: Tuesday, October 14
    Location: Virtual
  • Chardan 9th Annual Genetic Medicines Conference
    Panel Discussion: Genome Editing: Next Wave Technologies
    Date: Tuesday, October 21, 8:45 a.m. ET
    Location: New York, NY

Access to Presentations

Investors and stakeholders can access live webcasts of these crucial presentations through the "Investors" section of Editas Medicine's website. An archived replay will also be available for approximately 30 days following each event, allowing broader access to those interested in the company’s advancements.

About Editas Medicine

Editas Medicine stands at the forefront of revolutionizing the treatment of serious diseases through its pioneering gene editing capabilities. The company aims to bring transformative in vivo medicines enabled by CRISPR technology to patients worldwide. With a focus on developing, producing, and commercializing durable gene editing solutions, Editas Medicine continues to lead in the commercialization of gene editing therapies.

Stay Updated with Editas Medicine

For the latest news and scientific advancements, individuals are encouraged to visit Editas Medicine's official website. The company frequently shares updates regarding new research findings, partnerships, and events.

Frequently Asked Questions

What is the focus of Editas Medicine?

Editas Medicine focuses on developing transformative gene editing therapies using CRISPR technology to treat serious diseases.

When will the ESGCT Congress take place?

The ESGCT Congress is scheduled from October 7 to October 10.

Who will present at the congress for Editas Medicine?

Linda Burkly, Ph.D., Executive Vice President and Chief Scientific Officer, will present at the congress.

How can I access the presentations from the conference?

Presentations will be available on Editas Medicine's website in the "Posters & Presentations" section after the event.

What upcoming events will Editas Medicine participate in?

Editas Medicine will participate in the H.C. Wainwright Genetic Medicines Virtual Conference and the Chardan 9th Annual Genetic Medicines Conference in October.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mudrick Urges Doncasters to Test a Strategic Sale Now

Updated Category News Views 81

Castings are rarely glamorous until nobody can get them, and Mudrick Capital is betting that ugly little industrial reality could make Doncasters worth far more in a takeover than the market currently credits. The event-driven investor, which says it owns roughly 4.3% of DPC Holdings Limited, has asked the board to quietly evaluate strategic alternatives, including a sale...

Continue Reading
Vanguard's Digital Win Matters More Than a Trophy

Updated Category News Views 182

A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Point72 Breach Puts Cyber Controls Under the Microscope

Updated Category News Views 76

Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...

Continue Reading
Green Lumber Recall Raises a Serious Safety Question

Updated Category News Views 41

A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...

Continue Reading
Dario's WebMD Deal Opens a Vast, Unproven Channel Path

Updated Category News Views 141

One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 54

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 123

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Refund Delays Are Becoming an E-Commerce Sales Risk

Updated Category News Views 176

A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 120

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating Economic Growth and AI Trends for 2026

Updated Category News Views 182

Anticipating a Prosperous Economy in 2026 With the majority of stocks in the S&P 500 having reported their results for the most recent quarter, the financial landscape shows noteworthy improvements. Revenues have surged by 8.2%, marking the highest growth in nearly three years, and earnings have seen a remarkable increase of 16.5%. This impressive earnings growth is...

Continue Reading
Calfrac's Remarkable Financial Growth in Argentina's Market

Updated Category News Views 98

Calfrac’s Record Performance in the Third Quarter Calfrac Well Services Ltd. (TSX: CFW), known for its innovative oilfield services, reported impressive financial results this quarter. The company achieved remarkable revenue of $430.1 million for the period, maintaining consistency from the previous quarter despite some challenges in other regions. The company's...

Continue Reading
Transform Your Financial Future with EarnMining's App Today

Updated Category News Views 123

Revolutionizing Crypto Mining with EarnMining EarnMining is changing the game in the realm of cloud mining, offering a user-friendly app that allows anyone to earn from cryptocurrencies, including Bitcoin and Litecoin, without the burdens of high fees or complex technology. It’s a fresh approach that democratizes access to crypto mining, making it accessible for both...

Continue Reading
Essential Insights for UK Companies When Buying Software

Updated Category News Views 277

Essential Insights for UK Companies When Buying Software Buying software can be a significant investment for businesses, with the potential to enhance operations or, unfortunately, lead to regret if the wrong choices are made. Recent insights reveal that a notable percentage of UK businesses express regret over their software purchases within the last eighteen months. The...

Continue Reading
Natalie De Fazio Takes the Lead as Pinnacle Live's CEO

Updated Category News Views 441

Pinnacle Live Promotes Natalie De Fazio to CEO Experience Pinnacle Live, a premier provider of event technology and production services, is thrilled to announce the promotion of Natalie De Fazio from President to Chief Executive Officer. This exciting shift follows the decision of current CEO Eddy Eisenberg to transition into the role of Executive Chair of the Pinnacle...

Continue Reading